JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Scope & Guideline
Unraveling the complexities of heart health through science.
Introduction
Aims and Scopes
- Molecular Mechanisms in Cardiac Function:
Research on the molecular pathways that regulate cardiac function, including signaling cascades, gene expression, and metabolic processes that influence heart health. - Cardiovascular Disease Mechanisms:
Studies exploring the pathophysiology of various cardiovascular diseases such as heart failure, arrhythmias, and cardiomyopathies, emphasizing the cellular and molecular alterations involved. - Innovative Therapeutic Strategies:
Development and evaluation of novel therapeutic approaches, including gene therapy, stem cell therapy, and pharmacological interventions aimed at repairing or regenerating cardiac tissue. - Cardiac Regeneration and Repair:
Research focused on the mechanisms underlying cardiac regeneration, including the role of stem cells, extracellular matrix, and signaling pathways in promoting tissue repair. - Sex Differences in Cardiovascular Health:
Investigation of how biological sex influences cardiovascular health, disease prevalence, and treatment response, with a focus on molecular and cellular differences. - Integrative Omics Approaches:
Utilization of multi-omics technologies (genomics, proteomics, metabolomics) to provide comprehensive insights into cardiovascular biology and disease mechanisms.
Trending and Emerging
- Cardiovascular Metabolism:
An increasing focus on the role of metabolic pathways in cardiac health and disease, particularly how metabolic dysregulation contributes to conditions such as obesity, diabetes, and heart failure. - Gene Editing and Gene Therapy:
A surge in research utilizing CRISPR and other gene editing technologies to explore genetic underpinnings of cardiovascular diseases and develop targeted gene therapies. - Extracellular Vesicles and Cell Communication:
Emerging studies investigating the role of extracellular vesicles in intercellular communication and their potential as biomarkers or therapeutic agents in cardiovascular diseases. - Inflammation and Immunology in Cardiology:
Growing interest in understanding the immune response in cardiovascular diseases, particularly how inflammation contributes to disease progression and the potential for immunomodulatory therapies. - Single-Cell and Multi-Omics Approaches:
The adoption of single-cell sequencing and integrative multi-omics approaches is on the rise, allowing for a more detailed understanding of cellular heterogeneity and the molecular landscape of cardiovascular diseases. - Personalized Medicine and Cardiovascular Health:
A trend towards personalized approaches to cardiovascular disease management, incorporating genetic, molecular, and clinical data to tailor treatments to individual patients.
Declining or Waning
- Traditional Pharmacology:
There is a noticeable reduction in studies centered on traditional pharmacological approaches to treating heart disease, as the field shifts towards more innovative and targeted therapeutic strategies. - Basic Animal Models:
Research using basic animal models without advanced genetic manipulations or disease modeling techniques has decreased, reflecting a broader trend towards more sophisticated and translational modeling approaches. - Cardiac Imaging Techniques:
While imaging remains a crucial tool in cardiology, there is less emphasis on traditional imaging studies (e.g., echocardiography) in favor of molecular and cellular investigations that provide deeper mechanistic insights. - Aging Research in Cardiovascular Disease:
Although aging is a critical factor in cardiovascular health, publications specifically addressing aging-related mechanisms in a standalone manner have diminished, likely due to a shift towards integrated approaches that consider aging as a variable within broader studies.
Similar Journals
CARDIOVASCULAR RESEARCH
Unveiling the future of heart health research.CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.
Frontiers in Physiology
Fostering collaboration in the realm of physiology.Frontiers in Physiology, published by FRONTIERS MEDIA SA, is a leading open-access journal that has been at the forefront of physiological research since its inception in 2010. As a reputable publication based in Switzerland, it aims to foster the dissemination of groundbreaking findings across various domains of physiology, engaging a global audience of scholars and practitioners. With a commendable Q2 ranking in the fields of both general physiology and medical physiology for 2023, this journal stands out in its field, achieving a significant Scopus rank of #32/113 in medical physiology and #58/193 in biochemistry, genetics, and molecular biology. Frontiers in Physiology not only commits to maintaining high scholarly standards but also ensures that all its articles are freely accessible, thereby promoting collaborative knowledge exchange. With a clear focus on advancing our understanding of physiological processes, the journal plays a crucial role in the development of innovative approaches to health and disease, making it an essential resource for researchers, professionals, and students alike.
CARDIOVASCULAR PATHOLOGY
Connecting researchers and clinicians for better outcomes.CARDIOVASCULAR PATHOLOGY, published by Elsevier Science Inc, is a distinguished journal dedicated to the dissemination of high-quality research in the fields of cardiology, pathology, and cardiovascular medicine. With an ISSN of 1054-8807 and an E-ISSN of 1879-1336, this journal has established itself as a vital resource for researchers, clinicians, and students alike. It is positioned in the Q2 quartile for both cardiology and pathology, indicating its significant impact and relevance in these disciplines. The journal offers a platform for innovative studies, reviews, and clinical insights, aiming to enhance our understanding of cardiovascular conditions and their pathological underpinnings. With an H-index that showcases its scholarly influence, CARDIOVASCULAR PATHOLOGY is committed to advancing the field through rigorous peer review and open dialogue among professionals. The journal is accessible through institutional subscriptions, making it an essential reference point for ongoing research through its convergence of knowledge from 1992 through 2024.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Pioneering Insights in Physiological and Pharmacological SciencesCanadian Journal of Physiology and Pharmacology, published by Canadian Science Publishing, is a leading peer-reviewed journal dedicated to advancing knowledge in the fields of physiology and pharmacology. With an ISSN of 0008-4212 and an E-ISSN of 1205-7541, this journal has been at the forefront of biomedical research since its inception in 1964. The journal operates within a constrained access model, ensuring a selective dissemination of high-quality research, while maintaining its esteemed position in the Q3 quartile across multiple relevant categories such as Medicine, Pharmacology, and Physiology as of 2023. Researchers, professionals, and students alike will find the journal a valuable resource for emerging trends and comprehensive studies that shape contemporary science, as evidenced by its competitive Scopus rankings. The Canadian Journal of Physiology and Pharmacology is vital for fostering scholarly dialogue and innovation in the scientific community, encouraging contributions that promote a deeper understanding of physiological and pharmacological phenomena.
CELL PROLIFERATION
Bridging Knowledge Gaps in Cell Proliferation StudiesCELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.
Cardiogenetics
Unlocking the secrets of genetics in cardiovascular medicine.Cardiogenetics, published by MDPI, is a leading open-access journal dedicated to advancing the field of genetics as it pertains to cardiovascular health and diseases. Since its launch in 2011, this journal has been at the forefront of disseminating high-quality research that explores the genetic underpinnings of cardiovascular conditions, offering a platform for innovative studies, reviews, and case reports. With an ISSN of 2035-8253 and an E-ISSN of 2035-8148, Cardiogenetics aims to bridge the gap between genetic research and clinical application, helping researchers, healthcare professionals, and students stay abreast of the latest advancements and findings. The journal’s commitment to open access ensures that its valuable content is available to a global audience, fostering greater collaboration and knowledge sharing in the cardiovascular genetics community. By contributing to this dynamic field, Cardiogenetics plays a crucial role in improving patient outcomes and paving the way for personalized medicine in cardiology.
npj Regenerative Medicine
Exploring Breakthroughs in Regenerative Science.npj Regenerative Medicine, published by NATURE PORTFOLIO, is at the forefront of research and innovation in the field of regenerative medicine, fostering a deep understanding of cellular and molecular processes that can be leveraged for therapeutic advancements. Launched as an Open Access journal since 2016, it ensures wide dissemination of knowledge, allowing researchers, professionals, and students to access high-quality articles without barriers. With an impressive impact, it holds Q1 ratings across multiple categories including Biomedical Engineering, Cell Biology, Developmental Biology, and Medicine (miscellaneous) as of 2023, indicating its critical role in shaping contemporary scientific discourse. The journal ranks notably within the top 10% in multiple Scopus categories, indicating its commitment to publishing pioneering research that addresses pressing challenges in regenerative therapies. Addressing the dynamic convergence of disciplines, npj Regenerative Medicine is poised to not only impact academic thought but also translate into clinical applications, making it a pivotal resource for those invested in the future of medicine.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Driving Progress Through Peer-Reviewed ResearchINTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.
Journal of Cardiovascular Development and Disease
Leading the charge in cardiovascular research and discovery.Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.
Nature Cardiovascular Research
Transforming research into impactful cardiovascular solutions.Nature Cardiovascular Research, published by SpringerNature in Germany, stands as a premier journal dedicated to advancing the field of cardiovascular sciences. With an impressive 2023 categorization in the Q1 quartile across multiple disciplines—including Biochemistry, Genetics and Molecular Biology, Cardiology, and Medicine—this journal uniquely positions itself as a leading resource for pioneering research and innovative findings. Although currently not open access, it provides a rich repository of peer-reviewed articles that contribute directly to the evolving landscape of cardiovascular medicine. The journal aims to bridge the knowledge gap between basic science and clinical application, catering to researchers, healthcare professionals, and students alike who are immersed in the complexities of cardiovascular health. With robust Scopus rankings in key categories, Nature Cardiovascular Research is poised to shape future directions in the field, helping to foster a deeper understanding of cardiovascular diseases and their underlying mechanisms. Explore the latest research and be part of the conversation in one of the most impactful scientific domains.